11-12 September 2018 //  Lancaster Royal Hotel, London


Matthew Durdy

Mr Matthew Durdy

Chief Business Officer, Cell and Gene Therapy Catapult

Part of the team that created the Catapult, he is also an Executive Director. He is responsible for strategy, and finding, funding and transacting the business of the Catapult. He has been a champion of the early integration of healthcare economics and reimbursement expertise into decision- making and clinical product design in the sector.  He began his career in international investment banking and has successfully managed a number of biotechnology SMEs.   His first degree was from Oxford University in Biology and he has an MBA (High Honors) from Chicago Booth. He is a non-executive director of an immune-oncology company and periodically assists the UK Government and international organisations in the development of initiatives in healthcare innovation.


2017 Speakers

"It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance."

Bertrand Alexandre, Director, Marketing Europe, Celyad